Autologous serum enhances cardiomyocyte differentiation of rat bone marrow mesenchymal stem cells in the presence of transforming growth factor-β1 (TGF-β1)

In Vitro Cellular and Developmental Biology - Animal

Volumn 49, Issue 4, 2013, Pages 287-294

  Rouhi, Leila ^a   Kajbafzadeh, Abdol Mohammad ^b   Modaresi, Mehrdad ^c   Shariati, Mehrdad ^d   Hamrahi, Dariush ^e  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ISLAMIC AZAD UNIVERSITY   (Iran)

^d ISLAMIC AZAD UNIVERSITY   (Iran)

^e AJA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Autologous serum; Bone marrow mesenchymal stem cells; Cardiomyocyte differentiation; Fetal bovine serum; Serum free medium; Transforming growth factor 1

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CULTURE MEDIUM; CYTOLOGY; HEART MUSCLE CELL; MESENCHYMAL STROMA CELL; METABOLISM; RAT; SERUM;

ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; CULTURE MEDIA, SERUM-FREE; MESENCHYMAL STROMAL CELLS; MYOCYTES, CARDIAC; RATS; SERUM; TRANSFORMING GROWTH FACTOR BETA1;

BACTERIA (MICROORGANISMS); BOVINAE; RATTUS;

EID: 84877794454     PISSN: 10712690     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11626-013-9597-1     Document Type: Article

References (32)

1. Akhurst R. J.; Lehnert S. A.; Faissner A.; Duffie E. TGF beta in murine morphogenetic processes: the early embryo and cardiogenesis. Development 108: 645-56; 1990.
2. Beeres S. L.; Atsma D. E.; van der Laarse A.; Pijnappels D. A.; van Tuyn J.; Fibbe W. E.; de Vries A. A.; Ypey D. L.; van der Wall E. E.; Schalij M. J. Human adult bone marrow mesenchymal stem cells repair experimental conduction block in rat cardiomyocyte cultures. J. Am. Coll. Cardiol. 46: 1943-52; 2005.
3. Bogdanova A.; Berziņš U.; Bruvere R.; Eivazova G.; Kozlovska T. Adipose-derived stem cells cultured in autologous serum maintain the characteristics of mesenchymal stem cells. Proc. Latv. Acad. Sci., Sect. B, Nat. Exact Appl. Sci. 64: 106-13; 2010.
4. Burlacu A.; Rosca A. M.; Maniu H.; Titorencu I.; Dragan E.; Jinga V. Promoting effect of 5-azacytidine on the myogenic differentiation of bone marrow stromal cells. Eur. J. Cell Biol. 87: 173-84; 2008.
5. Chachques J. C.; Herreros J.; Trainini J.; Juffe A.; Rendal E.; Prosper F. Autologous human serum for cell culture avoids the implantation of cardioverter-defibrillators in cellular cardiomyoplasty. Int. J. Cardiol. 95: 29-33; 2004a.
6. Chachques J. C.; Herreros J.; Trainini J.; Juffe A.; Rendal E.; Prosper F.; Genovese J. Life-threatening arrhythmias after cellular cardioplasty. Autologous human serum for cell culture avoids the implantation of cardioverter-defibrillators in cellular cardiomyoplasty. Int. J. Cardiol. 95: S29-S33; 2004b.
7. Chen H. F.; Kuo H. C.; Chien C. L.; Shun C. T.; Yao Y. L.; Ip P. L.; Chuang C. Y.; Wang C. C.; Yang Y. S.; Ho H. N. Derivation, characterization and differentiation of human embryonic stem cells: comparing serum-containing versus serum-free media and evidence of germ cell differentiation. Hum. Reprod. 22: 567-77; 2007.
8. Chen S.; Lechleider R. J. Transforming growth factor-beta-induced differentiation of smooth muscle from a neural crest stem cell line. Circ. Res. 94: 1195-202; 2004.
9. Eslaminejad M. B.; Rouhi L.; Arabnajafi M.; Baharvand H. Rat marrow-derived mesenchymal stem cells developed in a medium supplemented with the autologous versus bovine serum. Cell Biol. Int. 33: 607-16; 2009.
10. Fukuhara S.; Tomita S.; Yamashiro S. Direct cell-cell interaction of cardiomyocytes is key for bone marrow stromal cells to go into cardiac lineage in vitro. J. Thorac. Cardiovasc. Surg. 125: 1470-80; 2003.
11. Gwak S. J.; Bhang S. H.; Yang H. S.; Kim S. S.; Lee D. H.; Lee S. H. In vitro cardiomyogenic differentiation of adipose-derived stromal cells using transforming growth factor-beta1. Cell Biochem. Funct. 27: 148-54; 2009.
12. Hahn J. Y.; Cho H. J.; Kang H. J.; Kim T. S.; Kim M. H.; Chung J. H.; Bae J. W.; Oh B. H.; Park Y. B.; Kim H. S. Pre-treatment of mesenchymal stem cells with a combination of growth factors enhances gap junction formation, cytoprotective effect on cardiomyocytes, and therapeutic efficacy for myocardial infarction. J. Am. Coll. Cardiol. 51: 933-43; 2008.
13. Horwitz E. M.; Gordon P. L.; Koo W. K.; Marx J. C.; Neel M. D.; McNall R. Y. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Proc. Natl. Acad. Sci. U. S. A. 99: 8932-7; 2002.
14. Kinnaird T.; Stabile E.; Burnett M. S. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ. Res. 94: 678-85; 2004.
15. Kocaoemer A.; Kern S.; Klüter H.; Bieback K. Human AB serum and thrombin-activated platelet-rich plasma are suitable alternatives to fetal calf serum for the expansion of mesenchymal stem cells from adipose tissue. Stem Cells. 25: 1270-8; 2007.
16. Kudo M.; Wang Y.; Wani M. A.; Xu M.; Ayub A.; Ashraf M. Implantation of bone marrow stem cells reduces the infarction and fibrosis in ischemic mouse heart. J. Mol. Cell. Cardiol. 35: 1113-9; 2003.
17. Li T. S.; Hayashi M.; Ito H.; Furutani A.; Murata T.; Matsuzaki M.; Hamano K. Regeneration of infarcted myocardium by intramyocardial implantation of ex vivo transforming growth factor-beta-preprogrammed bone marrow stem cells. Circulation 111: 2438-45; 2005a.
18. Li Y.; Powell S.; Brunette E.; Lebkowski J.; Mandalam R. Expansion of human embryonic stem cells in defined serum-free medium devoid of animal-derived products. Biotechnol. Bioeng. 91: 688-98; 2005b.
19. Liu Y.; Song J.; Liu W.; Wan Y.; Chen X.; Hu C. Growth and differentiation of rat bone marrow stromal cells: does 5-azacytidine trigger their cardiomyogenic differentiation? Cardiovasc. Res. 58: 460-8; 2003.
20. Macy E.; Bulpitt K.; Champlin R. E.; Saxon A. Anaphylaxis to infusion of autologous bone marrow: an apparent reaction to self, mediated by IgE antibody to bovine serum albumin. J. Allergy Clin. Immunol. 83: 871-5; 1989.
21. Nimura A.; Muneta T.; Koga H.; Mochizuki T.; Suzuki K.; Makino H.; Umezawa A.; Sekiya I. Increased proliferation of human synovial mesenchymal stem cells with autologous human serum: comparisons with bone marrow mesenchymal stem cells and with fetal bovine serum. Arthritis Rheum. 58: 501-10; 2008.
22. Ohnishi S.; Ohgushi H.; Kitamura S.; Nagaya N. Mesenchymal stem cells for the treatment of heart failure. Int. J. Hematol. 86: 17-21; 2007.
23. Passier R.; Oostwaard D. W.; Snapper J.; Kloots J.; Hassink R. J.; Kuijk E. Increased cardiomyocyte differentiation from human embryonic stem cells in serum-free cultures. Stem Cells. 23: 772-80; 2005.
24. Pountos I.; Georgouli T.; Giannoudis P. V. The effect of autologous serum obtained after fracture on the proliferation and osteogenic differentiation of mesenchymal stem cells. Cell. Mol. Biol. 54: 33-9; 2008.
25. Singla D. K.; Sun B. Transforming growth factor-b2 enhances differentiation of cardiac myocytes from embryonic stem cells. Biochem. Biophys. Res. Commun. 332: 135-41; 2005.
26. Stute N.; Holtz K.; Bubenheim M.; Lange C.; Blake F.; Zander A. R. Autologous serum for isolation and expansion of human mesenchymal stem cells for clinical use. Exp. Hematol. 32: 1212-25; 2004.
27. Sun X.; Gan Y.; Tang T.; Zhang X.; Dai K. In vitro proliferation and differentiation of human mesenchymal stem cells cultured in autologous plasma derived from bone marrow. Tissue Eng. Part A. 14: 391-400; 2008.
28. Taha M. F.; Valojerdi M. R. Effect of bone morphogenetic protein-4 on cardiac differentiation from mouse embryonic stem cells in serum-free and low-serum media. Int. J. Cardiol. 127: 78-87; 2008.
29. Tse H. F.; Kwong Y. L.; Chan J. K.; Lo G.; Ho C. L.; Lau C. P. Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. Lancet 361: 47-9; 2003.
30. Wei H. M.; Wong P.; Hsu L. F.; Shim W. Human bone marrow-derived adult stem cells for post-myocardial infarction cardiac repair: current status and future directions. Singap. Med. J. 50: 935-42; 2009.
31. Wollert K. C.; Meyer G. P.; Lotz J.; Ringes-Lichtenberg S.; Lippolt P.; Breidenbach C.; Fichtner S.; Korte T.; Hornig B.; Messinger D.; Arseniev L.; Hertenstein B.; Ganser A.; Drexler H. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 364: 141-8; 2004.
32. Yamamoto N.; Isobe M.; Negishi A.; Yoshimasu H.; Shimokawa H.; Ohya K. Effects of autologous serum on osteoblastic differentiation in human bone marrow cells. J. Med. Dent. Sci. 50: 63-9; 2003.